Patents by Inventor Marco THURNER

Marco THURNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230285467
    Abstract: The present invention relates to methods for obtaining skeletal muscle derived cells (SMDC), and the use of SMDCs in a method of preventing and/or treating neuromyopathies and/or myopathies, wherein the neuromyopathy and/or myopathy is incontinence, in particular a urinary and/or an anal or fecal incontinence.
    Type: Application
    Filed: March 8, 2023
    Publication date: September 14, 2023
    Applicant: INNOVACELL AG
    Inventors: Marco THURNER, Eva MARGREITER, Wolfgang SCHWAIGER, Faheem Muhammad ASIM, Rainer MARKSTEINER
  • Publication number: 20230240643
    Abstract: A guidance device is provided for facilitating the placement of a puncture device (a needle) at a defined position relative to an ultrasound probe. The guidance device provides additional support of a needle tip near the needle injection site to maintain a selected path throughout an injection. The additional support is automatically retracted for simple disposal with the used syringe after an injection. The guidance device minimizes contact of soiled components and enables syringe insertion, alignment, and removal for multiple different injections without removal of an ultrasound probe from the patient.
    Type: Application
    Filed: June 15, 2021
    Publication date: August 3, 2023
    Inventors: Craig Joseph CERMAK, Rainer MARKSTEINER, Marco THURNER
  • Patent number: 11617768
    Abstract: The present invention relates to methods for obtaining skeletal muscle derived cells (SMDC), and the use of SMDCs in a method of preventing and/or treating neuromyopathies and/or myopathies, wherein the neuromyopathy and/or myopathy is incontinence, in particular a urinary and/or an anal or fecal incontinence.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: April 4, 2023
    Assignee: INNOVACELL AG
    Inventors: Marco Thurner, Eva Margreiter, Wolfgang Schwaiger, Faheem Muhammad Asim, Rainer Marksteiner
  • Publication number: 20220145257
    Abstract: The present invention relates to methods for obtaining induced smooth muscle cells (iSMCs), iSMCs, iSMCs for use in a method of treating a disease or disorder or for use in tissue engineering, and the use of skeletal muscle derived cells for obtaining iSMCs.
    Type: Application
    Filed: March 23, 2020
    Publication date: May 12, 2022
    Inventors: Marco THURNER, Rainer MARKSTEINER
  • Publication number: 20210069255
    Abstract: The present invention relates to methods for obtaining skeletal muscle derived cells (SMDC), and the use of SMDCs in a method of preventing and/or treating neuromyopathies and/or myopathies, wherein the neuromyopathy and/or myopathy is incontinence, in particular a urinary and/or an anal or fecal incontinence.
    Type: Application
    Filed: December 14, 2018
    Publication date: March 11, 2021
    Inventors: Marco THURNER, Eva MARGREITER, Wolfgang SCHWAIGER, Faheem Muhammad ASIM, Rainer MARKSTEINER